Immunotherapy Stocks List
Symbol | Grade | Name | Weight |
---|---|---|---|
CNCR | D | Loncar Cancer Immunotherapy ETF | 12.7 |
AADR | C | WCM BNY Mellon Focused Growth ADR ETF | 6.19 |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 4.43 |
IBBJ | D | Defiance Nasdaq Junior Biotechnology ETF | 4.11 |
ARKG | D | ARK Genomic Revolution Multi-Sector ETF | 3.9 |
View all Immunotherapy related ETFs...
Compare ETFs
Date | Stock | Signal | Type |
---|---|---|---|
2021-02-26 | ADAG | New 52 Week Closing Low | Bearish |
2021-02-26 | ADAG | Hot IPO Pullback | Bullish Swing Setup |
2021-02-26 | ADAP | Fell Below 50 DMA | Bearish |
2021-02-26 | ADTX | Narrow Range Bar | Range Contraction |
2021-02-26 | ADTX | 50 DMA Support | Bullish |
2021-02-26 | ALPN | Stochastic Buy Signal | Bullish |
2021-02-26 | ALPN | Pocket Pivot | Bullish Swing Setup |
2021-02-26 | ALPN | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-02-26 | APTO | NR7 | Range Contraction |
2021-02-26 | APTO | New 52 Week Low | Weakness |
2021-02-26 | APTO | New 52 Week Closing Low | Bearish |
2021-02-26 | APTO | Lower Bollinger Band Walk | Weakness |
2021-02-26 | ARDS | Hammer Candlestick | Bullish |
2021-02-26 | ARDS | Lower Bollinger Band Walk | Weakness |
2021-02-26 | ARDS | Lizard Bullish | Bullish Day Trade Setup |
2021-02-26 | ARGX | Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup |
2021-02-26 | ATNM | New Downtrend | Bearish |
2021-02-26 | ATNM | Spinning Top | Other |
2021-02-26 | AVCO | 50 DMA Resistance | Bearish |
2021-02-26 | BLCM | NR7 | Range Contraction |
2021-02-26 | BLCM | 50 DMA Support | Bullish |
2021-02-26 | CDMO | Stochastic Reached Overbought | Strength |
2021-02-26 | CDMO | New 52 Week Closing High | Bullish |
2021-02-26 | CDMO | New 52 Week High | Strength |
2021-02-26 | CDMO | Pocket Pivot | Bullish Swing Setup |
2021-02-26 | CDMO | MACD Bullish Signal Line Cross | Bullish |
2021-02-26 | CDMOP | 20 DMA Support | Bullish |
2021-02-26 | CDMOP | Hammer Candlestick | Bullish |
2021-02-26 | CDTX | Fell Below 50 DMA | Bearish |
2021-02-26 | CLBS | New Downtrend | Bearish |
2021-02-26 | CLBS | MACD Bearish Centerline Cross | Bearish |
2021-02-26 | CLBS | Fell Below 200 DMA | Bearish |
2021-02-26 | CLBS | Fell Below 50 DMA | Bearish |
2021-02-26 | CNCR | New Downtrend | Bearish |
2021-02-26 | CNCR | Stochastic Reached Oversold | Weakness |
2021-02-26 | DBVT | Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup |
2021-02-26 | DBVT | 1,2,3 Pullback Bullish | Bullish Swing Setup |
2021-02-26 | DBVT | Bollinger Band Squeeze | Range Contraction |
2021-02-26 | DTIL | Crossed Above 50 DMA | Bullish |
2021-02-26 | DTIL | 180 Bullish Setup | Bullish Swing Setup |
2021-02-26 | ENLV | NR7 | Range Contraction |
2021-02-26 | EVAX | Hot IPO Pullback | Bullish Swing Setup |
2021-02-26 | EVAX | New 52 Week Closing Low | Bearish |
2021-02-26 | FBIO | 20 DMA Resistance | Bearish |
2021-02-26 | FBIOP | Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup |
2021-02-26 | FBIOP | NR7 | Range Contraction |
2021-02-26 | FBIOP | Narrow Range Bar | Range Contraction |
2021-02-26 | FBIOP | 1,2,3 Pullback Bullish | Bullish Swing Setup |
2021-02-26 | GLSI | Lower Bollinger Band Walk | Weakness |
2021-02-26 | GLSI | 1,2,3 Pullback Bullish | Bullish Swing Setup |
2021-02-26 | GNCA | NR7 | Range Contraction |
2021-02-26 | GNCA | 50 DMA Support | Bullish |
2021-02-26 | HARP | 20 DMA Resistance | Bearish |
2021-02-26 | HARP | Crossed Above 50 DMA | Bullish |
2021-02-26 | HARP | Pocket Pivot | Bullish Swing Setup |
2021-02-26 | HGEN | 50 DMA Resistance | Bearish |
2021-02-26 | IMCR | Hot IPO Pullback | Bullish Swing Setup |
2021-02-26 | IMRN | MACD Bearish Centerline Cross | Bearish |
2021-02-26 | IMTX | Bollinger Band Squeeze | Range Contraction |
2021-02-26 | IMTX | Volume Surge | Other |
2021-02-26 | IMTX | Fell Below 50 DMA | Bearish |
2021-02-26 | IMUX | Calm After Storm | Range Contraction |
2021-02-26 | IMV | NR7 | Range Contraction |
2021-02-26 | INMB | Lower Bollinger Band Walk | Weakness |
2021-02-26 | IOVA | Crossed Above 200 DMA | Bullish |
2021-02-26 | IOVA | Lower Bollinger Band Walk | Weakness |
2021-02-26 | IOVA | Pocket Pivot | Bullish Swing Setup |
2021-02-26 | IPHA | 50 DMA Support | Bullish |
2021-02-26 | IPHA | 20 DMA Support | Bullish |
2021-02-26 | IPHA | MACD Bullish Signal Line Cross | Bullish |
2021-02-26 | JNCE | 20 DMA Resistance | Bearish |
2021-02-26 | JNCE | Bearish Engulfing | Bearish |
2021-02-26 | LCTX | Doji - Bullish? | Reversal |
2021-02-26 | LCTX | Stochastic Reached Oversold | Weakness |
2021-02-26 | LCTX | 50 DMA Support | Bullish |
2021-02-26 | MBIO | Crossed Above 200 DMA | Bullish |
2021-02-26 | MBIO | Lower Bollinger Band Walk | Weakness |
2021-02-26 | MBIO | Doji - Bullish? | Reversal |
2021-02-26 | MBIO | New Downtrend | Bearish |
2021-02-26 | MRKR | Spinning Top | Other |
2021-02-26 | NBTX | Stochastic Buy Signal | Bullish |
2021-02-26 | NBTX | Lower Bollinger Band Walk | Weakness |
2021-02-26 | NEXI | New 52 Week Closing High | Bullish |
2021-02-26 | NKTX | Spinning Top | Other |
2021-02-26 | NKTX | MACD Bearish Signal Line Cross | Bearish |
2021-02-26 | NXTC | Stochastic Buy Signal | Bullish |
2021-02-26 | ONCS | Lower Bollinger Band Walk | Weakness |
2021-02-26 | ORIC | Fell Below 50 DMA | Bearish |
2021-02-26 | ORIC | Fell Below 20 DMA | Bearish |
2021-02-26 | PDSB | Stochastic Reached Oversold | Weakness |
2021-02-26 | SELB | Stochastic Buy Signal | Bullish |
2021-02-26 | SNSE | Hot IPO Pullback | Bullish Swing Setup |
2021-02-26 | SURF | Lower Bollinger Band Walk | Weakness |
2021-02-26 | SURF | New Downtrend | Bearish |
2021-02-26 | TCRR | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-02-26 | TCRR | Bollinger Band Squeeze | Range Contraction |
2021-02-26 | TCRR | 20 DMA Resistance | Bearish |
2021-02-26 | THMO | 50 DMA Support | Bullish |
2021-02-26 | THMO | New Downtrend | Bearish |
2021-02-26 | URGN | MACD Bearish Centerline Cross | Bearish |
Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.
Mike's Notes
- CGNT: Not a chart ...
- TDOC: One of sever...
- NFLX: I love these...
- CGEM: The Hot IPO ...
- X: A 17% breako...
From the Blog
Popular Now
Featured Articles
- Tech Stock Indices: Do Bulls Have A Problem?
- Robinhood Proxies – The Private and Public Markets Can Be Very Connected
- The Rise of Cult Stocks
- If you don’t know why you’re getting in, it will be even harder to get out
- Three Ways To Make Better Decisions in Markets
- Semi-automating Your Trading
- Recommended Stock Trading Books